• Product NameTroglitazone
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityTroglitazone is a PPARγ agonist with anti-inflammatory and anti-tumor activity.
• Target NamePPAR agonist
• CAS No. 97322-87-7
• Calculated MW 441.54
• Formulation C24H27NO5S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CC1=C(O)C(C)=C2CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)OC2=C1C
  Pathways:Metabolism
  Receptor:PPARγ
  Boling pt:
  Melting pt:
  Solubility:DMSO: 25mg/mL
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Yamazaki H, et al. In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting